The Yuan requests your support! Our content will now be available free of charge for all registered subscribers, consistent with our mission to make AI a human commons accessible to all. We are therefore requesting donations from our readers so we may continue bringing you insightful reportage of this awesome technology that is sweeping the world. Donate now
Oxford Drug Design leads the charge for an AI-powered cancer cure
By Oladimeji Ewumi  |  Jul 23, 2024
Oxford Drug Design leads the charge for an AI-powered cancer cure
Image courtesy of and under license from Shutterstock.com
A cancer cure once seemed like an ambitious yet distant dream. However, companies like Oxford Drug Design are transforming this dream into reality. The Yuan contributor, Oladimeji Ewumi, explores this exciting development in a recent interview, revealing how the landscape is changing for the better.

LISBON - Oxford Drug Design, a promising startup in the field of pharmaceuticals and biomedicine, features knowledgeable experts and tech that makes searching for a cure for any disease more affordable, time-effective, and accurate than previously possible. A process that once would have taken decades might now be just a few years away. Alan Roth, chief executive at Oxford Drug Design in the United Kingdom, recently sat down with The Yuan journalist and artificial intelligence (AI) expert Oladimeji Ewumi to discuss how his company is pioneering a new era of therapeutics and AI that will potentially transform how the world approaches drug design.

Alan, can you share the inspiration behind founding Oxford Drug Design and how AI plays such a pivotal role in your approach to drug discovery?

Oxford Drug Design was originally spun out from the chemistry laboratory of Prof Graham Richards at Oxford

The content herein is subject to copyright by The Yuan. All rights reserved. The content of the services is owned or licensed to The Yuan. Such content from The Yuan may be shared and reprinted but must clearly identify The Yuan as its original source. Content from a third-party copyright holder identified in the copyright notice contained in such third party’s content appearing in The Yuan must likewise be clearly labeled as such.
Continue reading
Sign up now to read this story for free.
- or -
Continue with Linkedin Continue with Google
Comments
Share your thoughts.
The Yuan wants to hear your voice. We welcome your on-topic commentary, critique, and expertise. All comments are moderated for civility.